Artificial Neural Networks to Optimize Formulation Components of a Fixed-Dose Combination of Rifampicin, Isoniazid and Pyrazinamide in a Microemulsion

B.D. Glass; S. Agatonovic-Kustrin; M.H. Wisch

doi:10.2174/1570163054866864

Artificial Neural Networks to Optimize Formulation Components of a Fixed-Dose Combination of Rifampicin, Isoniazid and Pyrazinamide in a Microemulsion

B.D. Glass, S. Agatonovic-Kustrin, M.H. Wisch

School of Molecular Sciences

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	195-201
Journal	Current Drug Discovery Technologies
Volume	2
DOIs	https://doi.org/10.2174/1570163054866864
Publication status	Published - 2005

Access to Document

10.2174/1570163054866864

Cite this

@article{080dce0d79944c8aa70b7c81a1f2c0fc,

title = "Artificial Neural Networks to Optimize Formulation Components of a Fixed-Dose Combination of Rifampicin, Isoniazid and Pyrazinamide in a Microemulsion",

author = "B.D. Glass and S. Agatonovic-Kustrin and M.H. Wisch",

year = "2005",

doi = "10.2174/1570163054866864",

language = "English",

volume = "2",

pages = "195--201",

journal = "Current Drug Discovery Technologies",

issn = "1570-1638",

publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Artificial Neural Networks to Optimize Formulation Components of a Fixed-Dose Combination of Rifampicin, Isoniazid and Pyrazinamide in a Microemulsion

AU - Glass, B.D.

AU - Agatonovic-Kustrin, S.

AU - Wisch, M.H.

PY - 2005

Y1 - 2005

U2 - 10.2174/1570163054866864

DO - 10.2174/1570163054866864

M3 - Article

VL - 2

SP - 195

EP - 201

JO - Current Drug Discovery Technologies

JF - Current Drug Discovery Technologies

SN - 1570-1638

ER -